Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics
- PMID: 30940874
- PMCID: PMC6760536
- DOI: 10.1038/s41435-019-0065-0
Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics
Abstract
Plague is a vector-borne disease caused by Yersinia pestis. Transmitted by fleas from rodent reservoirs, Y. pestis emerged <6000 years ago from an enteric bacterial ancestor through events of gene gain and genome reduction. It is a highly remarkable model for the understanding of pathogenic bacteria evolution, and a major concern for public health as highlighted by recent human outbreaks. A complex set of virulence determinants, including the Yersinia outer-membrane proteins (Yops), the broad-range protease Pla, pathogen-associated molecular patterns (PAMPs), and iron capture systems play critical roles in the molecular strategies that Y. pestis employs to subvert the human immune system, allowing unrestricted bacterial replication in lymph nodes (bubonic plague) and in lungs (pneumonic plague). Some of these immunogenic proteins as well as the capsular antigen F1 are exploited for diagnostic purposes, which are critical in the context of the rapid onset of death in the absence of antibiotic treatment (less than a week for bubonic plague and <48 h for pneumonic plague). Here, we review recent research advances on Y. pestis evolution, virulence factor function, bacterial strategies to subvert mammalian innate immune responses, vaccination, and problems associated with pneumonic plague diagnosis.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination and diagnostics.Microbes Infect. 2019 Jun-Jul;21(5-6):202-212. doi: 10.1016/j.micinf.2019.06.007. Epub 2019 Jun 25. Microbes Infect. 2019. PMID: 31252217
-
Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.Clin Vaccine Immunol. 2013 Feb;20(2):227-38. doi: 10.1128/CVI.00597-12. Epub 2012 Dec 12. Clin Vaccine Immunol. 2013. PMID: 23239803 Free PMC article.
-
Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.J Clin Microbiol. 2011 May;49(5):1708-15. doi: 10.1128/JCM.00064-11. Epub 2011 Mar 2. J Clin Microbiol. 2011. PMID: 21367990 Free PMC article.
-
Yersinia pestis and the plague.Am J Clin Pathol. 2003 Jun;119 Suppl:S78-85. doi: 10.1309/DQM9-3R8Q-NQWB-FYU8. Am J Clin Pathol. 2003. PMID: 12951845 Review.
-
Pneumonic Plague: The Darker Side of Yersinia pestis.Trends Microbiol. 2016 Mar;24(3):190-197. doi: 10.1016/j.tim.2015.11.008. Epub 2015 Dec 14. Trends Microbiol. 2016. PMID: 26698952 Review.
Cited by
-
Progress on the research and development of plague vaccines with a call to action.NPJ Vaccines. 2024 Sep 7;9(1):162. doi: 10.1038/s41541-024-00958-1. NPJ Vaccines. 2024. PMID: 39242587 Free PMC article. Review.
-
A global overview of the most important zoonotic bacteria pathogens transmitted from Rattus norvegicus to humans in urban environments.Infect Med (Beijing). 2022 Jul 30;1(3):192-207. doi: 10.1016/j.imj.2022.07.002. eCollection 2022 Sep. Infect Med (Beijing). 2022. PMID: 38077628 Free PMC article. Review.
-
How Pathogens Feel and Overcome Magnesium Limitation When in Host Tissues.Trends Microbiol. 2021 Feb;29(2):98-106. doi: 10.1016/j.tim.2020.07.003. Epub 2020 Aug 14. Trends Microbiol. 2021. PMID: 32807623 Free PMC article. Review.
-
Identification of Drug Targets and Their Inhibitors in Yersinia pestis Strain 91001 through Subtractive Genomics, Machine Learning, and MD Simulation Approaches.Pharmaceuticals (Basel). 2023 Aug 9;16(8):1124. doi: 10.3390/ph16081124. Pharmaceuticals (Basel). 2023. PMID: 37631039 Free PMC article.
-
The Use of an Organo-Selenium Peptide to Develop New Antimicrobials That Target a Specific Bacteria.Antibiotics (Basel). 2021 May 21;10(6):611. doi: 10.3390/antibiotics10060611. Antibiotics (Basel). 2021. PMID: 34063816 Free PMC article.
References
-
- Yersin A. La peste bubonique a Hong-Kong. Ann Inst Pasteur (Paris) 1894;8:662–7.
-
- Bertherat E. Plague around the world, 2010–2015. Wkly Epidemiol Rec. 2016;91:89–104. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
